Dolores Skarjune Sells Shares of Globe Life Inc.
Globe Life's EVP Dolores Skarjune sold 1,850 shares worth $331,483.
Key Points
- Dolores Skarjune, EVP and Chief Admin. Officer at Globe Life, sold 1,850 shares for $331,483 on June 30, 2026.
- Globe Life, trading at $179.25, has a market cap of $13.92 billion with a P/E ratio of 12.41 and a beta of 0.499.
- Analysts maintain a 'buy' consensus with a target mean price of $177.36, as TD Cowen set a $215 target on June 23.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Dolores Skarjune, the Executive Vice President and Chief Administrative Officer of Globe Life Inc., sold 1,850 shares of the company on June 30, 2026. The shares were sold at an average price of $179.18, totaling approximately $331,483. This transaction was not conducted under a pre-arranged trading plan.
Insider Buying and Selling at Globe Life Inc.
In addition to the recent sale by Dolores Skarjune, other insider transactions at Globe Life Inc. include Cheryl Alston's purchase of 14,017 shares at $105.56 and sale of 8,258 shares at $179.24 on June 25, 2026. These transactions were also not part of any pre-planned trading arrangements.
Globe Life Inc. Stock Up 3.4%
Shares of NYSE:GL traded near $179.25 on Tuesday. Globe Life Inc. has a market capitalization of $13.92 billion. The company sports a P/E ratio of 12.41 and a forward P/E of 10.77. The stock's beta is 0.499, indicating lower volatility compared to the market. Its 52-week low is $116.73, and its high is $181.15. The 50-day moving average is $157.81, while the 200-day moving average stands at $143.88.
$GL stock price
Daily closing prices, year to date. Not investment advice.
Analysts Set New Price Targets
On June 23, 2026, TD Cowen maintained its 'buy' rating on Globe Life with a price target of $215. Other firms like Piper Sandler and Morgan Stanley also maintain 'buy' ratings, with targets of $175 and $181, respectively. The consensus among analysts is a 'buy' recommendation, with a mean target price of $177.36 based on 11 analyst opinions.
About Globe Life Inc.
Globe Life Inc. is a life insurance company headquartered in McKinney, Texas. It offers various life and supplemental health insurance products aimed at lower-middle and middle-income families in the United States. The company operates through segments like Life Insurance and Supplemental Health Insurance, selling its products through direct-to-consumer channels and independent agents. Globe Life, led by CEO Frank Martin Svoboda, employs approximately 3,695 people.
Bottom Line
Dolores Skarjune's recent sale of Globe Life shares is a notable insider transaction, though it does not necessarily signal a change in the company's outlook. Globe Life continues to trade strongly, with analysts maintaining a positive outlook and setting high price targets. Investors often monitor such insider transactions to gauge potential shifts in company sentiment, but it's essential to remember that these filings reflect past actions.
Get Globe Life Inc. alerts
New 13F filings, insider trades, and analyst moves on $GL, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.